Babson Diagnostics $31 Million Series B to Drive
Retailization of Customer-First, Highly Accessible
Diagnostic Blood Testing
Funding Marks Latest Milestone on Path to Commercialization Babson Diagnostics, a transformative medical technology company improving customer access to…
